the Efficacy and Safety of CLAE in R/R T-ALL/LBL

Clinical trial NCT04679506 · UNKNOWN

Trial details

NCT number: NCT04679506
Sponsor: Peking University Third Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Start date: 2020-12-01
Primary completion: 2021-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.